Who
John N. Nunnelly
Director
Company insider
Files Form 4 as: Director, NRC Health.
In numbers
- Trades disclosed
- 449
- Buys
- 0
- Sells
- 94
- Bought
- $0
- Sold
- $9.7M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 4 May 2006
- Last trade
- 23 Jun 2026
- Last filed
- 25 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Jun 2026filed 25 Jun 2026 | NRC NRC HealthLife-science tools | SEC FORM 4 Code A | —7,697 at $0.00 | filing |
| 23 Jun 2026filed 25 Jun 2026 | NRC NRC HealthLife-science tools | SEC FORM 4 Code A | —7,697 at $0.00 | filing |
| 17 Oct 2025filed 21 Oct 2025 | NRC NRC Healthoption or derivative · Life-science tools | SEC FORM 4 Code A | —22,625 at $0.00 | filing |
| 7 May 2025filed 9 May 2025 | NRC NRC Healthoption or derivative · Life-science tools | SEC FORM 4 Code A | —34,917 at $0.00 | filing |
| 8 May 2024filed 10 May 2024 | NRC NRC Healthoption or derivative · Life-science tools | SEC FORM 4 Code A | —10,906 at $0.00 | filing |
| 27 Mar 2024filed 29 Mar 2024 | NRC NRC Healthoption or derivative · Life-science tools | SEC FORM 4 Code M | —9,259 at $0.00 | filing |
| 27 Mar 2024filed 29 Mar 2024 | NRC NRC HealthLife-science tools | SEC FORM 4 Code M | $138K9,259 at $14.95 | filing |
| 27 Mar 2024filed 29 Mar 2024 | NRC NRC HealthLife-science tools | SEC FORM 4 Code F | $138K3,487 at $39.70 | filing |
| 11 May 2023filed 15 May 2023 | NRC NRC Healthoption or derivative · Life-science tools | SEC FORM 4 Code A | —7,386 at $0.00 | filing |
| 18 May 2022filed 20 May 2022 | NRC NRC Healthoption or derivative · Life-science tools | SEC FORM 4 Code A | —12,078 at $0.00 | filing |
| 29 Jun 2021filed 1 Jul 2021 | NRC NRC Healthoption or derivative · Life-science tools | SEC FORM 4 Code A | —7,289 at $0.00 | filing |
| 23 Jul 2020filed 27 Jul 2020 | NRC NRC Healthoption or derivative · Life-science tools | SEC FORM 4 Code M | —5,926 at $0.00 | filing |
| 23 Jul 2020filed 27 Jul 2020 | NRC NRC Healthoption or derivative · Life-science tools | SEC FORM 4 Code M | —6,821 at $0.00 | filing |
| 23 Jul 2020filed 27 Jul 2020 | NRC NRC Healthoption or derivative · Life-science tools | SEC FORM 4 Code M | —40 at $0.00 | filing |
| 23 Jul 2020filed 27 Jul 2020 | NRC NRC HealthLife-science tools | SEC FORM 4 Code M | $58K5,926 at $9.74 | filing |
| 23 Jul 2020filed 27 Jul 2020 | NRC NRC HealthLife-science tools | SEC FORM 4 Code M | $345K6,821 at $50.62 | filing |
| 23 Jul 2020filed 27 Jul 2020 | NRC NRC HealthLife-science tools | SEC FORM 4 Code M | $1,39640 at $34.90 | filing |
| 23 Jul 2020filed 27 Jul 2020 | NRC NRC HealthLife-science tools | SEC FORM 4 Code F | $404K6,861 at $58.94 | filing |
| 23 Jul 2020filed 27 Jul 2020 | NRC NRC HealthLife-science tools | SEC FORM 4 Sold | $356K5,926 at $60.10 | filing |
| 18 May 2020filed 20 May 2020 | NRC NRC Healthoption or derivative · Life-science tools | SEC FORM 4 Code A | —7,179 at $0.00 | filing |
News
Head-To-Head Contrast: National Research (NASDAQ:NRC) & Teladoc Health (NYSE:TDOC)NRC · themarketsdaily.com · 10 Oct 2026Critical Contrast: Teladoc Health (NYSE:TDOC) vs. National Research (NASDAQ:NRC)NRC · tickerreport.com · 8 Oct 2026
0 headlines in the last 90 days name John N. Nunnelly; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.